Anti-trypanosomatid drug discovery: progress and challenges

Leishmaniasis (visceral and cutaneous), Chagas disease and human African trypanosomiasis cause substantial death and morbidity, particularly in low- and middle-income countries. Although the situation has improved for human African trypanosomiasis, there remains an urgent need for new medicines to t...

Descripción completa

Detalles Bibliográficos
Autores principales: De Rycker, Manu, Wyllie, Susan, Horn, David, Read, Kevin D., Gilbert, Ian H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395782/
https://www.ncbi.nlm.nih.gov/pubmed/35995950
http://dx.doi.org/10.1038/s41579-022-00777-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395782/
https://www.ncbi.nlm.nih.gov/pubmed/35995950
http://dx.doi.org/10.1038/s41579-022-00777-y

Ejemplares similares